Literature DB >> 32090050

Comment on "Intravitreal conbercept injection for neovascular age-related macular degeneration".

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Year:  2020        PMID： 32090050      PMCID： PMC7013791          DOI： 10.18240/ijo.2020.02.24

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  9 in total

1.  Intravitreal conbercept injection for neovascular age-related macular degeneration.

Authors:  Bing-Hui Wu; Bing Wang; Hui-Qin Wu; Qin Chang; Hui-Qin Lu
Journal:  Int J Ophthalmol       Date:  2019-02-18       Impact factor: 1.779

Review 2.  TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations.

Authors:  K Bailey Freund; Jean-François Korobelnik; Robert Devenyi; Carsten Framme; John Galic; Edward Herbert; Hans Hoerauf; Paolo Lanzetta; Stephan Michels; Paul Mitchell; Jordi Monés; Carl Regillo; Ramin Tadayoni; James Talks; Sebastian Wolf
Journal:  Retina       Date:  2015-08       Impact factor: 4.256

3.  High-frequency aflibercept injections in persistent neovascular age-related macular degeneration.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-08       Impact factor: 3.117

4.  Protective effect of intravitreal bevacizumab and sub-tenon triamcinolone acetonide against occlusion of choriocapillaris induced by photodynamic therapy.

Authors:  Ryo Mukai; Shoji Kishi; Taku Sato; Goro Watanabe; Hidetaka Matsumoto
Journal:  Ophthalmologica       Date:  2010-02-25       Impact factor: 3.250

5.  Choroidal Thickness Changes After Intravitreal Antivascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration: Ranibizumab Versus Aflibercept.

Authors:  Magda Gharbiya; Filippo Cruciani; Cesare Mariotti; Francesca Grandinetti; Marco Marenco; Vittorio Cacace
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-03       Impact factor: 2.671

6.  Short-term efficacy of intravitreal aflibercept depending on angiographic classification of polypoidal choroidal vasculopathy.

Authors:  Seongyong Jeong; Min Sagong
Journal:  Br J Ophthalmol       Date:  2016-09-05       Impact factor: 4.638

7.  Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).

Authors:  Sandeep Grover; Ravi K Murthy; Vikram S Brar; Kakarla V Chalam
Journal:  Am J Ophthalmol       Date:  2009-05-09       Impact factor: 5.258

Review 8.  Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.

Authors:  Chui Ming Gemmy Cheung; Timothy Y Y Lai; Paisan Ruamviboonsuk; Shih-Jen Chen; Youxin Chen; K Bailey Freund; Fomi Gomi; Adrian H Koh; Won-Ki Lee; Tien Yin Wong
Journal:  Ophthalmology       Date:  2018-01-10       Impact factor: 12.079

9.  Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types.

Authors:  Akiyuki Kawamura; Mitsuko Yuzawa; Ryusaburo Mori; Miho Haruyama; Koji Tanaka
Journal:  Acta Ophthalmol       Date:  2013-07-15       Impact factor: 3.761
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.